The relationship between the structure of the T cell antigen receptor (TCR)-CD3 complex and development of NKI
T cell population expressing NKI.1, a marker previously thought to be specific for natural killer cells, has been found in CD4+CD8 -T cells and CD4-CD8-T cells (1) (2) (3) (4) . The NKI.1 + TCR-oUj3 + T cells express skewed TCR Vc~ (5) and VB (1, 2, 4) families. Recently, a similar T cell population with a skewed TCR repertoire was also identified in human lymphocytes (5) (6) (7) . These T cells secrete several kinds of lymphokines, such as Ib2, II.-4, and IFN-7 (8, 9) . Furthermore, we have shown that NKI.1 + TCRci/B + thymocytes are the only population within the thymus that expresses Fas ligand and is cytotoxic against immature CD4 +CD8 + thymocytes expressing Fas antigen (10, 11) . NKI.1 + TCR-ci/13 + thymocytes appear to be an important population that may regulate the development of the immune system by secreting several different lymphokines (12) or by killing Fas-expressing cells (11) . Although both NKI.1 + CD4+CD8 -and NKI.1 + CD4-CD8-T cells were shown to be selected by 132-microglobulin-associated MHC class I antigen (13) (14) (15) (16) , it has remained unclear what antigen the NKI.1 + TCR-ci/B + T cells recognize and how the NKI.1 + TCR-cx/13 + T cells develop.
Recently, IL-2-activated NKI.1 + TCR-cx//3 + thymocytes were shown to express TCR complexes associated with FcR3, homodimers (17) similarly to CD8c~/ci + TCR-7/<3 + T cells in intestinal intraepithelial lymphocytes (18) (19) (20) . These studies raised the possibility that NKI.1 + TCR-cUB + thymocytes may have TCR complexes and signaling functions distinct from conventional NKI.1-T cells. In the present study, to understand the signals required for the development of NKI.1 + TCR-cx/{3 + T cells, we analyzed these populations in CD3~'-(21) and FcRT-deficient mice (22) . CD3~'was required for the development of these T ceUs, although FcR7 ddidency did not alter their development. On the other hand, the number of NKI.1 + TCR-7/~ + thymocytes significantly increased in CD3~'-ddident mice. These findings demonstrated that CD3~" has distinct roles in the development of not only the major NKI.1-T cells (20, 21, 23) but also of NKI.1 + T cells.
Materials and Methods
Mice. CD3~'-deficient mice were made as previously described (21) . FcRT-defident mice were kindly provided by Dr. J. V. Ravetch (The Rockefeller University, New York) (22) . These mice were maintained in our animal facility and back-crossed to C57BL/6 mice six times for CD3~'-defacient mice and three times for FcRT-defident mice, and NKI.1 expression was confirmed for all mice.
Cell Preparation. NKI.1 § TCR-~x/B + thymocytes were pre-pared by FACS | sorting as described previously (11) . (24) . Briefly, 3 x l& purified NKI.1 § TCR-odB + thymocytes and LN T cells were solubilized in lysis buffer (1% digitonin, 50 mM Tris-HC1, pH 7.6, 300 mM NaC1, 10 #g/ml aprotinin, 10 #g/ml leupeptin, 2.5 #g/ml antipain, 2.5 #g/ml chymostatin, 10 #g/ml pepstatin A, 1 mM PMSF, and 10 mM iodoacetamide). Immunoprecipitation was performed with anti-CD3 (2Cll) mAb precoupled by dimethylpimelimidate to protein A Sepharose (Pharmacia Biotech, Inc., Piscataway, NJ). The total precipitates were biotinylated as previously described (18) . After biotinylation, immunoprecipitates were resolved by two-dimensional nonreducing-reducing SDS-PAGE and transferred onto polyvinylidene fluoride membrane. The biotinylated protein on the membrane was detected by enzyme chemiluminescence as described previously (18) .
FACS | Analysis. 1 x 106 thymocytes or red cell-depleted splenocytes were stained with FITC-anti-heat stable antigen (HSA) mAb, PE-anti-NKl.1 mAb, and biotin-anti-CD3, TCR-od~ or TCR-qr/c5 mAb (all from Pharmingen, San Diego, CA), followed by Tricolor-streptavidin (Caltag Laboratories, San Francisco, CA). For analysis of various surface marker expressions, thymocytes were stained with FITC-anti-HSA mAb, PE-anti-NKl.1 mAb, and biotin-anti-CD4, -CDS, -CD44,-MEL-14 (LECAM-1) (all from Pharmingen)-IL-2RB (kindly provided by Dr. Miyasaka), or-IL--TR mAb (gratefully received from Dr. Nishikawa, Kyoto University, Japan), followed by Tricolor-streptavidin. The stained cells were analyzed by FACScan | (Becton Dickinson & Co., Mountain View, CA).
Results

Association ofFcR 7 with the TCR Complexes of Freshly Isolated NKI.1 + TCR-cr/~ + Thymocytes.
Recent analysis by S. Koyasu revealed that II~2-activated NKI.1 + TCR-ot/B + T cells express unique TCR complexes associated with FcR3' homodimers (17) . However, because of the limited number of these cells isolated from mice, analysis of the TCR complexes in freshly isolated NKI.1 + TCR-odB + T cells has been difficult. In the present study, we applied a newly developed sensitive labeling method (24) for analyzing the TCR complexes of freshly isolated NKI.1 + TCR-ot/B + thymocytes. As shown in Fig. 1 , immunoprecipitation of the TCR complexes of NKI.1 + TCR-c~/~ + thymocytes with antiCD3e mAb showed that the complexes contained CD3~" homodimers and CD3~'-FcR3, heterodimers. However, FcR3, homodimers, which were observed in the TCR complexes of ILo2-activated NKI.1 § T cells (17) , were not detected in the complexes of the freshly isolated NKI.1 § TCR-ot/~ + thymocytes. On the other hand, only CD3~" homodimers were detected in TCR complexes ofLN T cells as a representative population of the NKI.1-conventional T cells. Therefore, NKI.1 + TCR-ot/B + thymocytes seemed to possess a unique composition of the TCR-CD3 complexes, perhaps reflecting a distinct TCR signaling capability of these cells.
Requirement of CD3~'for Development of NKI.1 + TCR. ce/fl + T Cells. We next examined the functional differences between CD3~" and FcR3' expressed on NKI.1 + TCRot/~ + T cells in their development by using CD3~'-(21) and FcRq,-deficient mice (22) . Because NKI.1 + CD3 + thymocytes do not express HSA antigen in normal mice (1, 3, 4, 9) and in CD3~'-deficient mice (data not shown), we analyzed the expression of NKI.1 and TCR on HSA-thymocytes. As shown in Fig. 2 TCR-3r/~ + thymocytes were calculated (Fig. 3) . While the number of NKI.1 + TCR-oUB + thymocytes was reduced dramatically, the number of NKI.1 + TCR-3~/6 + thymocytes increased about six times in ~'-/-mice as compared with those in ~'+/-mice. This expansion of the NKI.1 + TCR-'y//~ + thymocyte population was not simply a reflection of a general increase of TCR-3U6 + T cells in ~'-/-mice, as the number of NKI.1-TCR-y//~ + thymocytes did not significantly increase in g'-l-mice, although their relative proportion within thymocytes increased (data not shown). Similar to thymocytes, the development of NKI.1 + TCRot/~ + T cells was also arrested, and NKI.1 + TCR-'y/6 + T cells were increased in the spleen of CD3~'-deficient mice (Fig. 2 B) . When FcR3~-deficient mice were analyzed, no obvious difference was observed in the development of NKI.1 + TCR-oUB + thymocytes as compared with wild-type mice (Fig. 2 C) . In addition, the development of NKI.1 + TCR-3~//~ + thymocytes, though small in number, was not affected by the lack of FcR'y expression (Fig. 2 C) . These findings indicate that the expression of CD3~" is essential for the development of NKI.1 + TCR-oU~ + T cells but not of NKI.1 + TCIL-~//~ + thymocytes. On the other hand, FcR% though involved in the TCR complexes of NKI.1 + TCRc~/~ + T cells, was not crucial for the development of NKI.1 + TCR-c~/3 + T cells.
Surface Phenotype of NKI.1 + TCR-9//cJ + Thymocytes in
CD3~'-deficient Mice. To characterize the novel NKI.1 + TCR-3,/6 + thymocytes that expanded in CD3~'-deficient mice, we analyzed the expression of several surface markers on NKI.1 + TCR-3,/~ + thymocytes. As previously reported (3, 4, 10, 25) , the surface phenotype of NKI.1 + TCR-~/fl + thymocytes is homogeneously CD8-CD44 + MEL-14-Ib 2RB + Ib7R +, and almost half of them express CD4 (Fig.  4) . When the surface phenotype of NKI.1 + thymocytes in ~'-/-mice (most were TCR-3,/~ + calls) was compared with that in ~'+/-mice (most were TCR-c~/~ § cells), almost all of the NKI.1 + TCR-3,/6 § thymocytes were CD8-CD44 + MEL-14-IL-2RB + IL-7R + , which was the same phenotype as NKI.1 + TCR-oUfl + thymocytes, except that most of the NKI.1 + TCR-3,/~ + thymocytes were CD4- (Fig. 4) .
Discussion
In the present study, we found that freshly isolated NKI.1 + TCK-oUfl + thymocytes express TCK complexes associated with CD3~'-FcR3' heterodimers as well as CD3~" homodimers. Considering that TCK complexes of most NKI.1-T cells do not contain FcR% NKI.1 + TCR-oUfl + thymocytes may possess a unique TCR signaling pathway via FcR% However, the development of NKI.1 + TCK- (26, 27) , and the number of NKI.1-TCR-'y/6 + thymocytes did not increase in our CD3~'-deficient mice, the expansion of NKI.1 + TCR-'~/6 + T cells does not seem to be merely a compensation for the reduction of TCR-odB + T cells in CD3~'-deficient mice. Therefore, we assume that the expansion of NKI.1 § TCR-'y/~ + T cells may result from the lack of signals through CD3~'. It is possible that signals through CD3~" on TCR-3,/6 + T cells may inhibit the development of NKI.1 + TCR-3,//~ + T cells in normal mice. Indeed, recent observations that the overexpression of CD3~" suppressed the recombination-activating gene expression and blocked the development of TCR-cx/13 + T cells (28) are consistent with this idea. Therefore, signals from CD3~" may regulate the development of thymocytes and T cells positively or negatively, depending on the developmental stages and specific properties of T cell subsets.
The development of NKI.1 + TCR-cx/3 + thymocytes was not altered in FcR3,-deficient mice (Fig. 2 B ) . Furthermore, NKI.1 + TCR-o~/~ + thymocytes from FcRy-defident mice responded to the stimulation by immobilized anti-TCR mAb and had grown in the presence of IL-2 as in normal mice (Arose, H., and T. Saito, unpublished observation). Therefore, FcR3~ does not seem to be critical for the development and function of NKI.1 + TCR-o~/B + T cells. However, considering that FcRy has an antigen recognition activation motif and transduces signals distinct from that through CD3~" in vitro (29) , it may contribute partly to the TCR signaling in NKI.1 + TCtL-oJj8 + thymocytes. Further studies will be required to clarify the function of FcR3' expressed in NKI.1 + TCR-c~/13 + thymocytes.
Collectively, it is concluded that at least three populations, NKI.1-TCR-cffl3 + T cells, NKI. 
